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On the Molecular Pharmacology of EndothelinA Receptors
1. The anti ET effects of CGRP may explain why pepper and garlic, beyond making 
our food taste great, serve a purpose for our cardiovascular health. (This thesis)
2. Different ET isoforms are not just for show, they serve a biologically relevant 
purpose. (This thesis)
3. When you attempt to antagonize a tightly bound agonist, take into consideration 
the tightness of your antagonist binding. (This thesis)
4. An agonist-dependent allosteric modulator may not only do more good than bad, 
but may do more of the good and less of the bad than a competitive antagonist. 
(This thesis)
5. “To keep this field of this highly exciting endothelin story going, each one of us 
should use their imagination in a positive way”. (Masashi Yanagisawa, ET-12)
6. “Since allosteric effects produce a change in shape of the receptor, it cannot be 
assumed a priori that a uniform antagonistic effect on agonism will result”. (Terry 
Kenakin, A Pharmacology Primer)
7. “Allosterism is the norm with just about everything”. (Arthur Christopoulos, Drug 
Discovery World)
8. “We have to remember that what we observe is not nature in itself, but nature 
exposed to our method of questioning”. (Werner Heisenberg, Physics and 
Philisophy)
9. “The universe we observe has precisely the properties we should expect if there 
is, at bottom, no design, no purpose, no evil and no good, nothing but blind 
pitiless indifference”. (Richard Dawkins, River Out of Eden)
10. “If you’re not prepared to be wrong, you will never come up with anything 
creative”. (Ken Robinson, The Element)
11. “Yeah, science!” (Jesse Pinkman, Breaking Bad)
